4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-22-000002
President and CEO acquired 62,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2022-01-03 | Grant or award | +62,000 | 213,691 | D | ||
| Derivatives | |||||||
| Watts Ryan J. President and CEO | 2022-01-03 | Grant or award · Stock Option (right to buy) | +186,500 | 186,500 | D | ||
Loading xslF345X03/wf-form4_164142738905570.xml…